These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9851171)

  • 1. [Wolman disease, Fabry disease and beta-galactosidase deficiency].
    Kitamura K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):393-6. PubMed ID: 9851171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acid lipase deficiency (Wolman disease and cholesteryl ester storage disease: CESD)].
    Tanaka A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):427-30. PubMed ID: 9645100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wolman disease and cholesteryl ester storage disease].
    Tanaka A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():337-40. PubMed ID: 11347090
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-galactosidase A in vascular disease.
    Bodary PF; Shayman JA; Eitzman DT
    Trends Cardiovasc Med; 2007 May; 17(4):129-33. PubMed ID: 17482095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role and mechanism of lysosomal acid lipase activity].
    Piskorska D; Kopieczna-Grzebieniak E
    Przegl Lek; 1988; 45(8):637-40. PubMed ID: 3070642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wolman disease].
    Tanaka A
    Nihon Rinsho; 2006 May; Suppl 1():750-2. PubMed ID: 16776266
    [No Abstract]   [Full Text] [Related]  

  • 7. Fabry disease.
    Schiffmann R
    Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition.
    Barbey F; Brakch N; Linhart A; Rosenblatt-Velin N; Jeanrenaud X; Qanadli S; Steinmann B; Burnier M; Palecek T; Bultas J; Hayoz D
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):839-44. PubMed ID: 16469946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease.
    Ameis D; Greten H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():66-7. PubMed ID: 8767467
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morquio syndrome, beta-galactosidase deficiency].
    Matsushita Y; Kuroiwa Y
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):466-7. PubMed ID: 11031995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fabry disease].
    Jakubowska E; Ryba M; Hruby Z
    Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stroke in Fabry disease. More than a simple stenosis].
    Politei JM
    Medicina (B Aires); 2006; 66(5):467-71. PubMed ID: 17137181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wolman disease successfully treated by bone marrow transplantation.
    Krivit W; Peters C; Dusenbery K; Ben-Yoseph Y; Ramsay NK; Wagner JE; Anderson R
    Bone Marrow Transplant; 2000 Sep; 26(5):567-70. PubMed ID: 11019848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multifunctional protective protein and its genetic deficiency 'galactosialidosis'].
    Sakuraba H; Itoh K; Shimmoto M
    Seikagaku; 1993 Jul; 65(7):561-6. PubMed ID: 8370987
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac manifestations of Fabry's disease: a story of mother and son.
    Moses H; Yarnoz MJ; Guglin M
    Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lysosomal acid lipase deficiency. Overview of Czech patients].
    Elleder M; Poupĕtová H; Ledvinová J; Hyánek J; Zeman J; Sýkora J; Stozický F; Chlumská A; Lohse P
    Cas Lek Cesk; 1999 Nov; 138(23):719-24. PubMed ID: 10746035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.